COVID-19 |
|
O.N. Kotenko, N.V. Vasina, V.E. Vinogradov
Organization of the Moscow City nephrology service during the pandemic of the new coronavirus infection COVID-19
|
8-9 |
|
E.M. Zeltyn-Abramov, N.I. Belavina, N.F. Frolova, L.Yu. Artyukhina, O.L. Podkorytova, V.V. Varyasin, V.V. Parshin, I.K. Maksimov, O.Yu. Evsyukov, E.A. Shishchenko
Stress-induced cardiomyopathy in a patient with a fulminant course of covid-19 early after a kidney allotransplantation
|
10-15 |
|
N.F. Frolova, S.S. Usatyuk, L.Yu. Artyukhina, O.N. Kotenko, V.V. Mayorov, M.A. Lysenko
New coronavirus infection covid-19 in a patient after kidney allotransplantation
|
16-20 |
ORIGINAL PAPERS |
|
K.D. Dorogoykina, D.S. Sedov, K.A. Gamayunova, A.P. Rebrov
Kidney condition in patients with spondyloarthritis receiving genetically engineered biologic drugs
|
21-25 |
|
K.S. Komissarov, K.S. Komissarov, M.V. Dmitrieva, T.A. Letkovskaya
Histopatological spectrum of kidney diseases according to renal biopsies performed in Minsk, Republic of Belarus
|
26-30 |
|
E.S. Stolyarevich, T.R. Zhilinskaya, V.V. Varyasin
Morphological structure of the kidney pathology according to the renal puncture biopsy data
|
31-36 |
|
D.V. Dolgalev, R.R. Kaliev
Chronic kidney disease in combination with chronic obstructive pulmonary disease under low-mountain conditions: risk factors, early detection and clinical and functional features
|
37-42 |
|
I.T. Murkamilov, K.A. Aitbaev, V.V. Fomin, Zh.A. Murkamilova, F.A. Yusupov, N.A. Redzhapova, Z.R. Rayimzhanov, A.I. Schastlivenko
Study of endothelial vascular growth factor, markers of inflammation and vascular stiffness in chronic kidney disease
|
43-51 |
CASE REPORTS |
|
M.S. Vetsheva, O.L. Podkorytova, L.Yu. Artyukhina, K.E. Loss, M.A. Lysenko
The combination of goodpasture syndrome and granulomatosis with polyangiitis
|
52-60 |
LITERATURE REVIEWS |
|
A.A. Ilyushkina, G.V. Baydakova, I.O. Bychkov, N.A. Buruleva, E.Yu. Zakharova
Selective screening for Fabry disease: review of literature data and experience in the Russian Federation
|
61-66 |
|
V.V. Dutov, D.M. Popov, S.V. Dutov, A.A. Rumyantsev, A.A. Podoynitsyn, S.Yu. Buymister, V.S. Goncharuk, M.T.S. Dadashov
Physiological basis for lithokinetic therapy. Part 2
|
67-73 |
|
G.V. Volgina, N.A. Mikhailovа
Ethelcalcetide in the treatment of secondary hyperparathyroidism in hemodialysis patients: a review of clinical data and a place in therapy
|
74-83 |
|
A.M. Esayan, A.R. Rind
The role of patient’s adherence in the treatment of hyperphosphatemia in chronic kidney disease
|
84-95 |
HISTORY OF NEPHROLOGY |
|
T.S. Morgoshia, D.V. Tishic
In memory of Marcello Malpighi (1628-1694) – an outstanding doctor and scientist-innovator (on the 325-th anniversary of his death)
|
96-101 |
Русский
